Literature DB >> 26703440

NB protein does not affect influenza B virus replication in vitro and is not required for replication in or transmission between ferrets.

Ruth A Elderfield1, Marios Koutsakos1, Rebecca Frise1, Konrad Bradley1, Jonathan Ashcroft1, Shanhjahan Miah2, Angie Lackenby2, Wendy S Barclay1.   

Abstract

The influenza B virus encodes a unique protein, NB, a membrane protein whose function in the replication cycle is not, as yet, understood. We engineered a recombinant influenza B virus lacking NB expression, with no concomitant difference in expression or activity of viral neuraminidase (NA) protein, an important caveat since NA is encoded on the same segment and initiated from a start codon just 4 nt downstream of NB. Replication of the virus lacking NB was not different to wild-type virus with full-length NB in clonal immortalized or complex primary cell cultures. In the mouse model, virus lacking NB induced slightly lower IFN-α levels in infected lungs, but this did not affect virus titres or weight loss. In ferrets infected with a mixture of viruses that did or did not express NB, there was no fitness advantage for the virus that retained NB. Moreover, virus lacking NB protein was transmitted following respiratory droplet exposure of sentinel animals. These data suggest no role for NB in supporting replication or transmission in vivo in this animal model. The role of NB and the nature of selection to retain it in all natural influenza B viruses remain unclear.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26703440      PMCID: PMC5381391          DOI: 10.1099/jgv.0.000386

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Transmembrane peptide NB of influenza B: a simulation, structure, and conductance study.

Authors:  W B Fischer; M Pitkeathly; B A Wallace; L R Forrest; G R Smith; M S Sansom
Journal:  Biochemistry       Date:  2000-10-17       Impact factor: 3.162

Review 2.  Molecular studies of influenza B virus in the reverse genetics era.

Authors:  David Jackson; Ruth A Elderfield; Wendy S Barclay
Journal:  J Gen Virol       Date:  2010-10-06       Impact factor: 3.891

3.  Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

Authors:  P A Rota; T R Wallis; M W Harmon; J S Rota; A P Kendal; K Nerome
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

4.  The NB protein is an integral component of the membrane of influenza B virus.

Authors:  T Betakova; M V Nermut; A J Hay
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

5.  The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Takeshi Noda; Maki Kiso; Junko Maeda; Shinji Watanabe; Yukiko Muramoto; Ken Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Influenza B virus NB glycoprotein is a component of the virion.

Authors:  D L Brassard; G P Leser; R A Lamb
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

7.  Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.

Authors:  Ruth A Karron; Peter F Wright; Robert B Belshe; Bhagvanji Thumar; Roberta Casey; Frances Newman; Fernando P Polack; Valerie B Randolph; Anne Deatly; Jill Hackell; William Gruber; Brian R Murphy; Peter L Collins
Journal:  J Infect Dis       Date:  2005-03-01       Impact factor: 5.226

8.  Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation.

Authors:  Kathy Triantafilou; Satwik Kar; Emmanouil Vakakis; Sailesh Kotecha; Martha Triantafilou
Journal:  Thorax       Date:  2013-01       Impact factor: 9.139

9.  Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly.

Authors:  Masaki Imai; Shinji Watanabe; Ai Ninomiya; Masatsugu Obuchi; Takato Odagiri
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.

Authors:  Geraldine Taylor; Sara Wyld; Jean-Francois Valarcher; Efrain Guzman; Michelle Thom; Stephanie Widdison; Ursula J Buchholz
Journal:  J Gen Virol       Date:  2014-04-03       Impact factor: 3.891

View more
  5 in total

Review 1.  Influenza B: Prospects for the Development of Cross-Protective Vaccines.

Authors:  Liudmila M Tsybalova; Liudmila A Stepanova; Edward S Ramsay; Andrey V Vasin
Journal:  Viruses       Date:  2022-06-17       Impact factor: 5.818

Review 2.  Reverse genetics for influenza B viruses and recent advances in vaccine development.

Authors:  Stivalis Cardenas-Garcia; C Joaquin Caceres; Daniela Rajao; Daniel R Perez
Journal:  Curr Opin Virol       Date:  2020-11-27       Impact factor: 7.090

Review 3.  The Development and Use of Reporter Influenza B Viruses.

Authors:  Rebekah E Dumm; Nicholas S Heaton
Journal:  Viruses       Date:  2019-08-09       Impact factor: 5.048

4.  Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.

Authors:  R Farrukee; A E Zarebski; J M McCaw; J D Bloom; P C Reading; A C Hurt
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

5.  Influenza A virus is transmissible via aerosolized fomites.

Authors:  Sima Asadi; Nassima Gaaloul Ben Hnia; Ramya S Barre; Anthony S Wexler; William D Ristenpart; Nicole M Bouvier
Journal:  Nat Commun       Date:  2020-08-18       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.